MoonLake Immunotherapeutics (MLTX) Financials

$48.89

$1.03 (2.15%)
Last update: 01:00 PM EST
Day's range
$47.87
Day's range
$49.24
$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning20202020202120212022202220232023202420243%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

MLTX Income statement / Annual

Last year (2024), MoonLake Immunotherapeutics's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, MoonLake Immunotherapeutics's net income was -$120.68 M. See MoonLake Immunotherapeutics,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $13.16 K $12.36 K $4.97 K $0.00
Gross Profit $0.00 -$13.16 K -$12.36 K -$4.97 K $0.00
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $111.39 M $31.79 M $42.05 M $35.52 M $0.00
General & Administrative Expenses $30.32 B $22.32 M $23.01 M $21.66 M $0.00
Selling & Marketing Expenses -$30.29 B $0.00 $0.00 $18.03 M $0.00
Selling, General & Administrative Expenses $30.32 M $22.32 M $23.01 M $18.05 M $105.76 K
Other Expenses $0.00 $0.00 $591.73 K $0.00 $0.00
Operating Expenses $141.71 M $54.12 M $65.06 M $53.57 M $105.76 K
Cost And Expenses $0.00 $54.12 M $65.06 M $53.58 M $105.76 K
Interest Income $0.00 $0.00 $0.00 $0.00 $14.92 K
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $13.16 K $12.36 K $4.97 K $206.30 K
EBITDA -$119.58 M -$54.11 M -$65.05 M -$53.63 M -$90.84 K
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $0.00 $10.14 M $591.73 K $10.65 M $14.92 K
Income Before Tax -$120.96 M -$43.98 M -$64.47 M -$53.64 M -$90.84 K
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $282.20 K $94.39 K $36.37 K $4.76 K -$206.30 K
Net Income -$120.68 M -$36.01 M -$64.51 M -$53.64 M -$90.84 K
Net Income Ratio 0 0 0 0 0
EPS -1919.51 -0.73 -2.2 -6.84 -0.0061
EPS Diluted -1919.51 -0.73 -2.2 -6.84 -0.0061
Weighted Average Shares Out $62.87 M $49.12 M $29.36 M $7.84 M $14.81 M
Weighted Average Shares Out Diluted $62.87 M $49.12 M $29.36 M $7.84 M $14.81 M
Link